LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Radicicol | 3.33 | uM | LJP6 | 3 | K08 | 72 | hr | 1401 | 1322 | 4272 | 0.3094 | -0.0357 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 1 | K08 | 72 | hr | 1401 | 2229 | 3978 | 0.5603 | 0.3610 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 2 | K08 | 72 | hr | 1401 | 1336 | 4213 | 0.3171 | -0.0297 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 3 | K08 | 72 | hr | 1401 | 1244 | 4545 | 0.2737 | -0.0678 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 1 | K07 | 72 | hr | 1401 | 927 | 4139 | 0.2240 | -0.2325 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 2 | K07 | 72 | hr | 1401 | 987 | 4095 | 0.2410 | -0.2028 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 3 | K07 | 72 | hr | 1401 | 854 | 4272 | 0.1999 | -0.2651 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 1 | K07 | 72 | hr | 1401 | 1132 | 3978 | 0.2845 | -0.1323 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 2 | K07 | 72 | hr | 1401 | 990 | 4213 | 0.2350 | -0.1966 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 3 | K07 | 72 | hr | 1401 | 1161 | 4545 | 0.2554 | -0.1050 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 1401 | 4258 | 4139 | 1.0288 | 1.0366 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 2 | G18 | 72 | hr | 1401 | 4611 | 4095 | 1.1259 | 1.1593 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 3 | G18 | 72 | hr | 1401 | 4550 | 4272 | 1.0650 | 1.0799 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 1401 | 3924 | 3978 | 0.9863 | 0.9817 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 1401 | 4109 | 4213 | 0.9753 | 0.9687 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 1401 | 4479 | 4545 | 0.9853 | 0.9826 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 1401 | 3621 | 4139 | 0.8749 | 0.8360 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 1401 | 3798 | 4095 | 0.9274 | 0.9049 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 1401 | 3746 | 4272 | 0.8768 | 0.8430 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 1401 | 4183 | 3978 | 1.0514 | 1.0677 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 1401 | 4574 | 4213 | 1.0856 | 1.1062 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 1401 | 4792 | 4545 | 1.0541 | 1.0631 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 1401 | 2106 | 4139 | 0.5088 | 0.2978 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 1401 | 1931 | 4095 | 0.4715 | 0.2302 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1401 | 1907 | 4272 | 0.4464 | 0.2111 |